The following pages link to Restenosis: the cost to society. (Q40478572):
Displaying 18 items.
- Physical characterization of alginate-Pluronic F127 gel for endoluminal NABDs delivery. (Q30782165) (← links)
- Abciximab. An updated review of its use in ischaemic heart disease (Q33504164) (← links)
- A case for minimally invasive coronary surgery as primary treatment for left anterior descending coronary artery disease (Q33805101) (← links)
- Abciximab. A pharmacoeconomic review of its use in percutaneous coronary revascularisation (Q33867830) (← links)
- Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy (Q34453226) (← links)
- Biodegradable nanoparticles for drug and gene delivery to cells and tissue (Q35082117) (← links)
- Restenosis after PCI. Part 1: pathophysiology and risk factors (Q37930965) (← links)
- Transfection efficiency and cytotoxicity of nonviral gene transfer reagents in human smooth muscle and endothelial cells (Q40542525) (← links)
- Antiplatelet therapy: Do the new platelet inhibitors add significantly to the clinicl benefits of aspirin? (Q41660109) (← links)
- Design of a muscle cell-specific expression vector utilising human vascular smooth muscle alpha-actin regulatory elements (Q42477185) (← links)
- Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease (Q46603985) (← links)
- Acute and long-term cost implications of coronary stenting (Q56928574) (← links)
- The French randomized optimal stenting trial: a prospective evaluation of provisional stenting guided by coronary velocity reserve and quantitative coronary angiography (Q57243554) (← links)
- Coronary stent implantation throughout technical evolution: immediate and follow-up results (Q58303383) (← links)
- Restenosis after Angioplasty (Q73595290) (← links)
- Differential restenosis rate of individual coronary artery sites after multivessel angioplasty: implications for revascularization strategy. CABRI Investigators. Coronary Angioplasty versus Bypass Revascularisation Investigation (Q74434332) (← links)
- Medical therapies for the prevention of restenosis after percutaneous coronary interventions (Q77522059) (← links)
- Novel stents for the prevention of restenosis (Q83207662) (← links)